MSD has been found to activate the microglial cells and increase the expression levels of proinflammatory cytokines, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α), in the hippocampus, accompanied by depression and cognitive impairment (Zhao et al., 2014). Here, TNF is linked to depressive symptom measurement.